Vimarsana.com

Latest Breaking News On - Simonmed imaging - Page 1 : vimarsana.com

Myriad Genetics, Onsite Women's Health Partner to ID Women With High Breast Cancer Risk

The program makes Myriad's hereditary breast cancer and risk assessment tools available to Onsite's pool of over 400,000 patients.

Paul-diaz
Onsite-women-health
Myriad-genetics
Onsite-women
Simonmed-imaging

Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2023 Earnings Call Transcript

Matthew Scalo: Okay. Good afternoon, and welcome to the Myriad Genetics First Quarter 2023 Earnings Call. During the call, we will review the financial results we released today.

California
United-states
South-san-francisco
Salt-lake-city
Utah
Salt-lake
America
Matthew-scalo
Mark-verratti
Mason-carrico
Puneet-souda
Nicole-lambert

vimarsana © 2020. All Rights Reserved.